Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-10-07

FDA Approved: ONDANSETRON — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved a supplemental application for ondansetron submitted by Sun Pharmaceutical Industries (ANDA077557). Ondansetron is a generic antiemetic used to pre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ondansetron (ondansetron)

Snippet

SUPPL AP for ONDANSETRON (ONDANSETRON)